Septic shock remains a major concern in critically ill patients. Morbidity, as reflected by cardiovascular instability and sequential organ failure, is high and mortality ranges from 20 to 50 % [1]. Treatment options are scarce and mainly causeoriented and symptomatic. Substantial efforts to control the coordinate but sometimes profuse and potentially lethal sepsis-induced immuno-inflammatory response remained unsuccessful. Indeed, large studies investigating numerous “magic bullets” interfering with sepsis-related immuneinflammatory or coagulation processes failed to show efficacy on relevant outcome parameters [2–4]. Also, the theoretical benefit of blood purification by restoring immune homeostasis through indiscriminate removal of inflammatorymediators could not be confirmed [5]. In this context, the paper of Li et al. is highly welcomed. The authors convincingly demonstrate a protective effect of nobiletin, a citrus flavone present in the peels of tangerine, mandarin and oranges, in murine endotoxic shock [6]. Interestingly, apart from inhibiting the “usual pro-inflammatory suspects” tumor necrosis factor-α and interleukin (IL)-6, the study focuses on two key protagonists within the sepsis cascade: high mobility group box-1 (HMGB-1) protein and nuclear factor kappa B (NF-κB) [6]. HMGB-1 is a late mediator of endotoxin lethality [7] and perfectly fits all criteria for an “alarmin” [8]. Alarmins form the endogenous branch of the larger family of damage-associated molecular patterns (DAMPs) that are released by threatened, injured, or necrotic cells [9]. In the nucleus, HMGB-1 stabilizes nucleosome formation and facilitates transcription factor binding. Outside the cell, it functions as a cytokine with weak direct pro-inflammatory activity [10] but considerable ability for indirect triggering of inflammation [11]. HMGB-1, indeed, acts as a potent chemoattractant for neutrophils, monocytes, macrophages, and dendritic cells and engages, among others, Toll-like, IL-1, and receptors for advanced glycation end-products (RAGE) that sustain or enhance the inflammatory process. Moreover, HMGB-1 and endotoxin synergistically reinforce each other at both receptor level and in activating transcriptional responses [11]. Severe sepsis [12] and acute inflammatory lung injury [13] are associated with lifethreatening out-of-control HMGB-1 responses. Thus, it makes perfect sense that measures for keeping the HMGB-1 release in check may dramatically influence the course of sepsis. Inhibiting HMGB-1 in murine sepsis protected against development of organ injury and reversed lethality [14]. Nosaka et al. recently showed that administration of amonoclonal antibody against HMGB1 suppressed the immuno-inflammatory response and significantly improved severe lung injury and survival in patients affected with H1N1 influenza A virus [15]. HMGB-1 is also effectively cleared by highly adsorptive dialysis membranes such as the acrylonitrile 69 surface-treated filter [16] which is increasingly used for continuous renal replacement therapy (CRRT) in hemodynamically unstable septic patients [17]. Though obviously an attractive and more easily available alternative for counteracting the noxious effects of HMGB1, clinical efficacy and benefit of such CRRT approach has not yet been established. 1 ICU Deparment, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium 2 ICU Deparment, UZ Brussel—VUB University, 101, Laarbeeklaan, 1090 Jette Brussels, Belgium 3 To whom correspondence should be addressed at ICU Deparment, UZ Brussel—VUB University, 101, Laarbeeklaan, 1090 Jette Brussels, Belgium. E-mail: Patrick.Honore@az.vub.ac.be
Read full abstract